Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Frequent p16/MTS1 inactivation in early stages of urothelial carcinoma of the bladder is not associated with tumor recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP895307.RASrRuO3AYM2OiE60rA7ZytTB75H_rUXaTy2-rWdJtbQE130_assertion description "[Frequent p16/MTS1 inactivation in early stages of urothelial carcinoma of the bladder is not associated with tumor recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP895307.RASrRuO3AYM2OiE60rA7ZytTB75H_rUXaTy2-rWdJtbQE130_provenance.
• NP895662.RAcpcfiZwIHdeIa7a2Zqa70cryC9RlTrL3cbcfst43kh0130_assertion description "[Frequent p16/MTS1 inactivation in early stages of urothelial carcinoma of the bladder is not associated with tumor recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP895662.RAcpcfiZwIHdeIa7a2Zqa70cryC9RlTrL3cbcfst43kh0130_provenance.
• assertion description "[Frequent p16/MTS1 inactivation in early stages of urothelial carcinoma of the bladder is not associated with tumor recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Frequent p16/MTS1 inactivation in early stages of urothelial carcinoma of the bladder is not associated with tumor recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Frequent p16/MTS1 inactivation in early stages of urothelial carcinoma of the bladder is not associated with tumor recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP615367.RA3v690bHCwvHz8av6Pfi1WOqB3_ofm6Hf704H3Udp1dg130_assertion description "[Frequent p16/MTS1 inactivation in early stages of urothelial carcinoma of the bladder is not associated with tumor recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP615367.RA3v690bHCwvHz8av6Pfi1WOqB3_ofm6Hf704H3Udp1dg130_provenance.
• NP885448.RA7sBm89_JWQe42KYB9xsAPvkxHlbkh8XGHxsWxhIPr_8130_assertion description "[Frequent p16/MTS1 inactivation in early stages of urothelial carcinoma of the bladder is not associated with tumor recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP885448.RA7sBm89_JWQe42KYB9xsAPvkxHlbkh8XGHxsWxhIPr_8130_provenance.
• NP306863.RAe47qOzfsUFrNZ-TuP2peS-JnUMH9_IgSzn9YooZw5v4130_assertion description "[Frequent p16/MTS1 inactivation in early stages of urothelial carcinoma of the bladder is not associated with tumor recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP306863.RAe47qOzfsUFrNZ-TuP2peS-JnUMH9_IgSzn9YooZw5v4130_provenance.
• NP678060.RAe1V3nO_JkDKIyG_TZkXZr7o3H39LLLtVmZRv_u_prGM130_assertion description "[Frequent p16/MTS1 inactivation in early stages of urothelial carcinoma of the bladder is not associated with tumor recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP678060.RAe1V3nO_JkDKIyG_TZkXZr7o3H39LLLtVmZRv_u_prGM130_provenance.
• NP475672.RAEIVBvaHsuDGYOVtwbxksCjl_165UjtaTwBP57pcw4C8130_assertion description "[Frequent p16/MTS1 inactivation in early stages of urothelial carcinoma of the bladder is not associated with tumor recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP475672.RAEIVBvaHsuDGYOVtwbxksCjl_165UjtaTwBP57pcw4C8130_provenance.
• assertion description "[Frequent p16/MTS1 inactivation in early stages of urothelial carcinoma of the bladder is not associated with tumor recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Frequent p16/MTS1 inactivation in early stages of urothelial carcinoma of the bladder is not associated with tumor recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Frequent p16/MTS1 inactivation in early stages of urothelial carcinoma of the bladder is not associated with tumor recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Frequent p16/MTS1 inactivation in early stages of urothelial carcinoma of the bladder is not associated with tumor recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Frequent p16/MTS1 inactivation in early stages of urothelial carcinoma of the bladder is not associated with tumor recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Frequent p16/MTS1 inactivation in early stages of urothelial carcinoma of the bladder is not associated with tumor recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP678220.RAAXMdqU5BCqfBp8DYV_lqg3NlmMf_r66wYS1owxsMd7g130_assertion description "[Frequent p16/MTS1 inactivation in early stages of urothelial carcinoma of the bladder is not associated with tumor recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP678220.RAAXMdqU5BCqfBp8DYV_lqg3NlmMf_r66wYS1owxsMd7g130_provenance.
• NP680743.RAmAoPH0NTTVj-E7VAHGLLN4r6fb5RQcNBj6okWkeC74Y130_assertion description "[Frequent p16/MTS1 inactivation in early stages of urothelial carcinoma of the bladder is not associated with tumor recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP680743.RAmAoPH0NTTVj-E7VAHGLLN4r6fb5RQcNBj6okWkeC74Y130_provenance.
• NP680850.RAl8C5jzu_ufQZhZq3sI-3oHWwZ2pLinkcRgUn5XGxRhE130_assertion description "[Frequent p16/MTS1 inactivation in early stages of urothelial carcinoma of the bladder is not associated with tumor recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP680850.RAl8C5jzu_ufQZhZq3sI-3oHWwZ2pLinkcRgUn5XGxRhE130_provenance.
• NP306109.RA5R060O3_M841Q9oG7iAiD_qeE6I5s3cJj6RW7vZJHe0130_assertion description "[Frequent p16/MTS1 inactivation in early stages of urothelial carcinoma of the bladder is not associated with tumor recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP306109.RA5R060O3_M841Q9oG7iAiD_qeE6I5s3cJj6RW7vZJHe0130_provenance.
• NP677823.RA6lFNCmdIce3xHBvOVTS1vv_Fz1ojlccM4i48NWt5fV8130_assertion description "[Frequent p16/MTS1 inactivation in early stages of urothelial carcinoma of the bladder is not associated with tumor recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP677823.RA6lFNCmdIce3xHBvOVTS1vv_Fz1ojlccM4i48NWt5fV8130_provenance.
• NP680907.RAxVCI356V3AH_7EBGvCQNIzMtii657j80OnVIh_jceWE130_assertion description "[Frequent p16/MTS1 inactivation in early stages of urothelial carcinoma of the bladder is not associated with tumor recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP680907.RAxVCI356V3AH_7EBGvCQNIzMtii657j80OnVIh_jceWE130_provenance.